Acadia Pharmaceuticals ACAD Amortization of capitalized software and acquired intangible assets
Amortization of capitalized software and acquired intangible assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's amortization of capitalized software and acquired intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Acadia Pharmaceuticals (ACAD) reported amortization of capitalized software and acquired intangible assets of $2.72M in Q1 2026.
- How has Acadia Pharmaceuticals's amortization of capitalized software and acquired intangible assets changed year-over-year?
- Acadia Pharmaceuticals's amortization of capitalized software and acquired intangible assets decreased by 0.0% year-over-year, from $2.72M to $2.72M.
- What is the long-term trend for Acadia Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's amortization of capitalized software and acquired intangible assets has grown at a 74.7% compound annual growth rate (CAGR), from $1.17M to $10.89M.